Loading...

JOURNAL OF CANCER RESEARCH AND ONCOBIOLOGY (ISSN:2517-7370)

About the Journal

Recently Published Articles

Research

Relationship between pretreatment serum LDH and clinical characteristics, laboratory findings and histological type in Hodgkin lymphoma patients: A Single Center Experience in Syria

Corresponding Author: Firas Hussein M. D*, Tishreen University Hospital, Head of Internal Medicine Department, Head of Clinical Hematology Department, Associate Professor in clinical Hematology, Lattakia, Syrian Arab Republic.
Pdf Full text Views (1966)

Case Report

A Rare Case of Lactic Acidosis Associated with Small Lymphocytic Lymphoma

Corresponding Author: Sushil K. Mehandru, MD FACP, Hackensack Meridian School of Medicine Jersey Shore University Medical Center, Professor of Medicine, Neptune, New Jersey, United States.
Pdf Full text Views (884)

Research Article

The Onco-genomic Landscape of Malignant Melanoma: The Tumor Microenvironment comes of Age

Corresponding Author: Pierluigi Scalia, Temple University, Sbarro Institute for Cancer Research and Molecular Medicine, Philadelphia, United States.
Pdf Full text Views (10518)

Research Article

Isoform A of Lactate Dehydrogenase (LDH-A), a Potential Ultra-early, High Sensitivity Biomarker of Tumorigenesis

Corresponding Author: Prieto Gratacós, Ernesto, ORCID ID: 0000-0002-0323-7041, Centro de Terapia Metabólica Buenos Aires, Italy.
Pdf Full text Views (3239)

Research Article

The Burden of Colorectal Cancers in Nigeria: Patterns and Presentations in North-Eastern Nigeria

Corresponding Author: Adamu Ningi, Abubakar Tafawa Balewa University Teaching Hospital, Department of Surgery, Bauchi, Nigeria.
Pdf Full text Views (2546)

Editorial Team

The Journal of Cancer Research and Oncobiology (JCRO) is an international, peer-reviewed, open access journal published by Boffin Access Limited. Dedicated to advancing knowledge in cancer biology and clinical oncology, the journal serves as a trusted platform for researchers, oncologists, clinicians, and healthcare professionals to publish high-quality research that addresses the mechanisms, diagnosis, treatment, and prevention of cancer.

JCRO aims to integrate basic, translational, and clinical research to accelerate the discovery of novel therapies and improve patient outcomes across diverse cancer types.

Aims and Scope

The Journal of Cancer Research and Oncobiology welcomes contributions in all areas of oncology and cancer biology, including but not limited to:

  • Molecular and cellular mechanisms of tumor initiation and progression

  • Cancer genetics, epigenetics, and genomics

  • Tumor immunology, immunotherapy, and checkpoint inhibitors

  • Precision medicine, targeted therapies, and personalized oncology

  • Radiotherapy, chemotherapy, and combination treatment approaches

  • Cancer biomarkers for diagnosis, prognosis, and therapeutic monitoring

  • Experimental oncology and preclinical cancer models

  • Oncogenic signaling pathways and tumor microenvironment studies

  • Epidemiology, prevention, and early cancer detection strategies

  • Clinical trials, case studies, and novel therapeutic interventions

  • Palliative care, survivorship, and quality-of-life research in oncology

Why Publish with JCRO?

  • Global Visibility – Open access ensures your research is freely available to scientists, clinicians, and policymakers worldwide.

  • Rigorous Peer Review – Submissions undergo double-blind peer review to ensure scientific quality and originality.

  • Rapid Publication – Fast-track editorial processing allows timely dissemination of impactful cancer research.

  • Expert Editorial Board – Managed by distinguished oncologists, cancer biologists, and clinical researchers.

  • Multidisciplinary Scope – Bridges laboratory discoveries with clinical oncology, fostering translational impact.

  • Author Rights – Authors retain copyright under Creative Commons licensing, supporting wide reuse and citation.

  • High Impact Potential – Articles benefit from digital promotion, indexing, and distribution across academic networks.

Editorial & Ethical Standards

The Journal of Cancer Research and Oncobiology adheres to the ethical publishing principles outlined by COPE and ICMJE. Manuscripts are evaluated based on scientific merit, with complete transparency, fairness, and confidentiality maintained throughout the editorial process.

Subjects covered by the Journal of Cancer Research and Oncobiology

  • Molecular and cellular pathobiology
  • Prevention and cancer epidemiology
  • Tumor and stem cell biology
  • Cancer therapeutics and targets
  • Microenvironment and immunology
  • Molecular alterations or biomarkers that predict response
  • Progression of the malignant phenotype
  • Large-scale molecular characterization of human tumors
  • Single and combined drug administration modalities
  • Carcinogenesis
  • Tumor immunology and virology
  • Oncogenomics, proteomics and metabolomics
  • Molecular targeted agents and immune therapies
  • Autologous stem cell transplant
  • Cancer vaccine
  • Electrofulguration
  • Hereditary prostate cancer genes
  • Invasive lobular carcinoma
  • Waldenstrom macroglobulinemia
  • Cellular Division and Proliferation
  • Stem Cell Biology
  • Cellular Signal Pathways
  • Wiskott-Aldrich syndrome
  • Chronic myelogenous leukemia
  • In situ non-invasive cancer
  • Intestinal cancer symptoms
  • Metastatic ovarian cancer
  • Oat cell cancer symptoms
  • Pituitary gland cancer
  • Squamous cell carcinoma
  • Advanced metastatic breast cancer
  • Philadelphia chromosome-positive chronic myelogenous leukemia
  • Osteosarcoma
  • Intestinal cancer symptoms
  • Hairy cell leukemia symptoms
  • Acute granulocytic leukemia
  • Burkitts lymphoma
  • Cancer Statistics
  • Wilms Tumour
  • Tumor Progression
  • Genetic Toxicology
  • Anti-Cancer Drug Discovery
  • Clinical Oncology

Open Access Journals

Abstracting and Indexing

SCINEXI use Crossref Similarity Check for averting plagiarism

Retractions

SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.

If you wish to report a concern regarding any published article, please share the details with us by clicking below:

Send Information

Subscribe to our Newsletter

Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.

Feedback

At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.

Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com